Oregon Bio is pleased to offer programming to support the bioscience industry and our member companies. Below are select signature event highlights. For upcoming events, please visit our Upcoming Events page.
Bio in the High Desert | What’s Brewing
July 17, 2022 | Bend, Oregon
Oregon Bioscience Association and Bend Chamber teamed up to cohost this event, held at the new $49 million dollar Edward J. Ray Hall on the OSU Cascades Campus. As usual, there was a great deal of networking, and the program included:
- Liisa Bozinovic, Executive Director, Oregon Bioscience Association providing an overview of the new 2022 Economic Impact Report.
- Panel Discussion: The next phase for Central Oregon bioscience?
Oregon Bio Women 2022 CONNECT
Lessons Learned of Connection & Resilience
July 7, 2022 | Lake Oswego, Oregon
The 2022 signature event for Oregon Bio Women (OBW) included a keynote speech by Emily Leproust, CEO and CoFounder of Twist Bioscience, which has built its factory of the future in Wilsonville,OR. Other program highlights included women leaders who discussed their career pathologies, career management strategies, how to building trust while protecting boundaries, as well as the continuing drive for diversity. The rollout announcement of the new OBW Mentorship program rounded out the program.
With 29,890 jobs held by women and 14,430 jobs employing minorities (as of 2020) the OBW connect program celebrated the sharing of real-world experiences of leadership, personal growth, work/life balance and allyship.
Oregon Pavilion at BIO International Convention 2022
June 13 -16, 2022 | San Diego, CA
The Oregon Bioscience Association partnered with Business Oregon and several other sponsors to create and host the Oregon Pavilion at BIO International Convention 2022. The Pavilion hosted several Oregon based bioscience sponsoring firms – from startups to public traded corporations. While participants engaged in biotech related networking, the booth itself celebrate the Oregon lifestyle with iconic landscape scenery.
Steve Thompson, Global Trade Specialist for Business Oregon, shared his take on the experience:
The Oregon Pavilion definitely stood out from the crowd with its theme of Where science and life come together, coupled with images of iconic Oregon scenery. The Oregon companies that attended BIO 2022 reported having a tremendous response to their products and services, and almost all said it exceed their expectations!
Although online tools like Zoom, Microsoft Teams and Google Meet are certainly efficient ways to conduct events and connect with people, there is really nothing like meeting with someone in person. One of our attendees had a great analogy about the difference – “virtual events only allow for two out of our five senses to be used.”
As a Global Trade Specialist, bioscience is one of my key target industries, and although I’m very familiar with many of Oregon’s bioscience firms, attending BIO 2022 was a fantastic opportunity to get to know them on a more personal level and meet many new ones as well.
Bio on the Rocks
April 6, 2022 | Hillsboro, OR
Oregon Bio’s second major in-person event coming out of the pandemic featured programming and networking inside the Octagonal Barn at McMenamins Cornelius Pass Roadhouse. The evening’s program featured:
- Liisa Bozinovic, Executive Director, Oregon Bioscience Association, with sneak preview of the Oregon Bio’s upcoming Economic Impact Report
- Rocky Dallum, Oregon Bio’s Government and Advocacy consultant (and partner with the local firm Tonkon Torp) on the recently concluded Oregon legislative session.
- Tim Layton, Director, State Government Affairs, Genentech moderating a a panel discussion with bio-entrepreneurs David A. Katz, Ph.D., founder and CSO of Sparrow Pharmaceuticals, Inc. and Erik I. Tucker, Ph.D., president and CEO of Aronora, Inc.
Oregon Biotech Summit
Biomarker Testing and the Promise of Precision Medicine
November 12, 2021 | Online
Oregon Bio’s 2021 Biotech Summit brought together biotech industry experts, researchers, providers, patient advocates, public leaders and policymakers to learn about and discuss the science and application of biomarker testing, how biomarkers have advanced treatment for so many patients and the critical need to make testing more accessible and ultimately drive improved patient outcomes and health care equity for Oregonians and Washingtonians. The Summit was completed by a virtual tour of Genentech’s new 130,000-square-foot Hillsboro Individualized Therapies (HIT) facility, a $175-million state-of-the-art new manufacturing facility for individualized therapies located in Hillsboro, Oregon.
You can hear and view the panel presentations in the video here. Let us know what you’ve learned.